GeoVax Labs, Inc. 8K

GeoVax Labs, Inc. agreed to induce holders to exercise existing warrants for cash in exchange for new 200% coverage unregistered warrants, while committing to register the new warrant shares, seek stockholder approval, and observe temporary restrictions on additional and variable‑rate equity issuances.

On August 25, 2026, GeoVax Labs, Inc. entered into an inducement offer with certain holders of its existing registered common stock purchase warrants dated February 17, 2026, March 31, 2026, May 8, 2026, and May 19, 2026, under which the holders are encouraged to exercise all such warrants for cash by August 25, 2026 in exchange for receiving new unregistered five‑year warrants to purchase a number of shares equal to 200% of the exercised warrant shares at an exercise price of $0.64 per share, subject to Nasdaq stockholder approval. The agreement includes a 4.99% beneficial ownership blocker, detailed provisions for removal of restrictive legends and penalties for delays, Public Information Failure liquidated damages if Rule 144 current information is not maintained, restrictions on additional equity issuances and variable rate transactions through specified dates in 2026, and covenants by the company to file a resale registration statement on Form S-1 for the new warrant shares and to seek prompt stockholder approval. GeoVax also represents that it is current in its SEC filings, has authority to enter the transaction, will deliver the warrant shares via DTC against payment, will list the new warrant shares on Nasdaq (while acknowledging an outstanding Nasdaq delisting notice), and will publicly disclose the material terms via press release or Form 8-K immediately after execution.

Filing Facts

CIK

832489

Ticker

-

Form

8K

Source Type

sec

Accession

0001437749-26-029181

Alert Tier

7